Scotts Miracle-gro CO Form 4 insider transactions

NYSE
Director Peter E. Shumlin exercised deferred stock units, converting them into common shares of Scotts Miracle-Gro on January 31, 2025.
NYSE
Director Nick Miaritis acquired 3,765 common shares of Scotts Miracle-Gro through a non-open market transaction.
NYSE
Director Roberto Candelino reports acquiring and disposing of common shares of Scotts Miracle-Gro on January 31, 2025.
NYSE
Scotts Miracle-Gro's Chairman and CEO, James Hagedorn, exercised stock options and sold a portion of his holdings on January 30, 2025.
NYSE
A Scotts Miracle-Gro executive, Christopher Hagedorn, exercised stock options and sold a portion of his holdings on January 30, 2025.
NYSE
Christopher Hagedorn, an EVP at Scotts Miracle-Gro, acquired 3,823.1 shares of common stock at a price of $56.76 per share on December 24, 2024.
NYSE
Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, acquired 6,221 shares of phantom stock on January 27, 2025.
NYSE
James Hagedorn, CEO of Scotts Miracle-Gro, reported acquiring common shares and phantom stock, while also disposing of some common shares.
NYSE
Scotts Miracle-Gro CEO James Hagedorn converted phantom stock units into common shares and disposed of some shares to cover tax obligations.
NYSE
James Hagedorn, CEO and Chairman of Scotts Miracle-Gro, acquired 1,339.542 shares of phantom stock on December 26, 2024.
NYSE
Executive Vice President, CFO, and Chief Administrative Officer of Scotts Miracle-Gro, Garth Matthew E., reports a transaction of common shares.
NYSE
Nathan E. Baxter, EVP and COO of Scotts Miracle-Gro, reports a transaction involving common shares held through a partnership.
NYSE
Scotts Miracle-Gro CEO James Hagedorn reported the acquisition of common shares through two transactions and details of his beneficial ownership, including shares held indirectly through a 401(k) plan and a partnership.
NYSE
A Scotts Miracle-Gro executive, Christopher C. Hagedorn, exercised stock options to acquire company shares.
NYSE
The Hagedorn Partnership sold a substantial number of Scotts Miracle-Gro Co. common shares in multiple transactions on December 9, 2024.
NYSE
Robert Hagedorn, a director at Scotts Miracle-Gro, sold a total of 108,550 common shares in two transactions on December 9, 2024.
NYSE
James Hagedorn, CEO and Chairman of Scotts Miracle-Gro, acquired 1,740.647 shares of phantom stock on December 6, 2024.
NYSE
Director Edith Aviles acquired 58 dividend equivalent rights related to Scotts Miracle-Gro common stock on December 6, 2024.
NYSE
David C. Evans, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights linked to existing share-based awards.
NYSE
Adam Hanft, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights linked to his existing stock-based compensation.
NYSE
Roberto Candelino has filed a document regarding dividend equivalent rights related to his holdings in Scotts Miracle-Gro Co.
NYSE
Katherine Hagedorn Littlefield, a director at Scotts Miracle-Gro, acquired 15 dividend equivalent rights on December 6, 2024.
NYSE
Mark D. Kingdon, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights linked to his existing stock awards.
NYSE
Nathan Eric Baxter, EVP and COO of Scotts Miracle-Gro, sold 11,359 common shares in multiple transactions on December 9, 2024.
NYSE
Peter E. Shumlin, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights tied to previously awarded stock units.
NYSE
Stephen L. Johnson, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights tied to his existing stock awards.
NYSE
John R. Vines, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights linked to his existing stock-based compensation.
NYSE
Thomas N. Kelly Jr., an executive at Scotts Miracle-Gro Co., has been granted dividend equivalent rights linked to previously awarded stock units.
NYSE
Brian E. Sandoval, a director at Scotts Miracle-Gro, acquired 101 dividend equivalent rights on December 6, 2024.
NYSE
Scotts Miracle-Gro CEO and Chairman James Hagedorn sold 18,368 common shares at an average price of $75.6769 on December 4, 2024.